Yahoo Finance Insider Sale: Director Richard Fisher Sells Shares of Tenet Healthcare Corp (THC)
On May 7, 2024, Richard Fisher, Director at Tenet Healthcare Corp (NYSE:THC), sold 2,500 shares of the company. The transaction was filed on the same day with the SEC. Over the past year, the insider has sold a total of 10,600 shares and has not purchased any shares.
Tenet Healthcare Corp operates as a diversified healthcare services company that primarily provides acute care hospital services, ambulatory care, and diagnostic imaging services. The company operates in several regions across the United States.
On the date of the sale, shares of Tenet Healthcare Corp were priced at $123.2, resulting in a market cap of approximately $12.47 billion. The price-earnings ratio of the company stood at 4.95, significantly below the industry median of 24.82.
According to the GF Value, the intrinsic value estimate for Tenet Healthcare Corp is $80.40 per share, suggesting that the stock is significantly overvalued with a price-to-GF-Value ratio of 1.53.
The insider transaction history for Tenet Healthcare Corp shows no insider buys over the past year, with a total of 10 insider sells recorded in the same period.
The GF Value is calculated based on historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
